Gonadotropin-releasing hormone agonists (GnRH-a) are common treatment options for central precocious puberty (CPP) in childhood. GnRH-a treatment is useful and has a good safety profile, with minimal adverse effects and no severe long-term consequences. The common side effects in children are menopause-like symptoms and local adverse events at the injection site.
Does the risk of arterial hypertension increase in the course of triptorelin treatment?
Palma, LauraWriting – Original Draft Preparation
;Gaudino, Rossella;Cavarzere, Paolo;Antoniazzi, Franco
2020-01-01
Abstract
Gonadotropin-releasing hormone agonists (GnRH-a) are common treatment options for central precocious puberty (CPP) in childhood. GnRH-a treatment is useful and has a good safety profile, with minimal adverse effects and no severe long-term consequences. The common side effects in children are menopause-like symptoms and local adverse events at the injection site.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
2019 Palma PP.pdf
non disponibili
Descrizione: articolo in fase di stampa
Tipologia:
Documento in Post-print
Licenza:
Accesso ristretto
Dimensione
94.85 kB
Formato
Adobe PDF
|
94.85 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
